• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Type  Injury  
Event Description
The jada system did not work and there was blood coming out from our the cervical seal and the patient continued to bleed [device ineffective].The vacuum pores were clogged with clots in them [device occlusion].Case narrative: this spontaneous report originating from the united states was received from a physician via clinical educator, referring to a female patient.The patient's medical history, concomitant medications and drug reactions/allergies were not reported.The patient's concurrent conditions included disseminated intravascular coagulation (dic) prior to the insertion of vacuum-induced hemorrhage control system (jada system).The patient was pregnant (pregnancy) and had delivery.This report concerned 1 patient and 1 device.On an unknown date, the patient underwent vacuum-induced hemorrhage control system (jada system) insertion via vaginal route (lot# and expiration date were not reported) for postpartum bleeding (postpartum hemorrhage).The patient continued to bleed, and the blood came out from the cervical seal and the vacuum-induced hemorrhage control system (jada system) did not work and did not control the bleeding (device ineffective), and it was removed.It was observed that the vacuum pores were clogged with clots in the vacuum-induced hemorrhage control system (jada system) (device occlusion) and the physician (provider) used the bakri balloon as an escalating treatment to stop/ control the abnormal postpartum uttering bleeding/ hemorrhage.It was reported that the patient sought medical attention.It was reported that operator of the device was the attending trained physician who was not a first-time user and received training on the usage of vacuum-induced hemorrhage control system (jada system) on an unknown date.The provider did not mention if any blood products were used during peripartum period.The device was not removed and reinserted for any reasons.It was reported that the vacuum-induced hemorrhage control system (jada system) came in a blue seal valve, kit, and green carton.For vacuum-induced hemorrhage control system (jada system), the serial number was not available.Therapy with vacuum-induced hemorrhage control system (jada system) was discontinued.The outcome of device ineffective and device occlusion was unknown.The reporter's causality assessment was not provided.Upon internal review, the event ¿device ineffective¿ was determined to be medically significant.Medical device reporting criteria: serious injury.(b)(4).
 
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key15853498
MDR Text Key304207369
Report Number3002806821-2022-00011
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-